Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Iteos Therapeutics, Inc. (ITOS)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 44,210,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   iTeos Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of a differentiated immuno-oncology therapeutics for patients. Co.'s product candidate, inupadenant, is designed as a selective small molecule antagonist of the adenosine A2a receptor, in the adenosine pathway, a main driver of immunosuppression in the tumor microenvironment across a range of tumors. Co.'s main antibody product candidate, EOS-448, is an antagonist of T-cell immunoreceptor with Ig and ITIM domains, an immune checkpoint with multiple mechanisms of action leading to immunosuppression.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 4,958,978 4,963,978 4,968,978
Total Buy Value $0 $38,685,562 $38,724,197 $38,766,047
Total People Bought 0 1 2 2
Total Buy Transactions 0 2 3 4
Total Shares Sold 0 2,668,407 2,668,407 2,668,407
Total Sell Value $0 $22,281,230 $22,281,230 $22,281,230
Total People Sold 0 5 5 5
Total Sell Transactions 0 16 16 16
End Date 2025-07-06 2025-04-04 2024-10-04 2023-10-05

   
Records found: 274
  Page 1 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Mcgrath Yvonne Chief Scientific Officer   •       –      –    2025-08-29 4 D $0.00 $0 D/D (46,300) 0     -
   Gall Matthew Chief Financial Officer   •       –      –    2025-08-29 4 D $0.00 $0 D/D (89,429) 0     -
   Feltquate David Chief Medical Officer   •       –      –    2025-08-29 4 D $0.00 $0 D/D (47,000) 0     -
   Detheux Michel Chief Executive Officer   •       •      –    2025-08-29 4 D $0.00 $0 I/I (94,027) 0     -
   Detheux Michel Chief Executive Officer   •       •      –    2025-08-29 4 D $0.00 $0 D/D (153,903) 0     -
   Call Matthew Chief Operating Officer   •       –      –    2025-08-29 4 D $0.00 $0 D/D (161,898) 0     -
   Detheux Michel Chief Executive Officer   •       –      –    2025-06-10 4 OE $4.30 $593,013 I/I 137,910 94,027     -
   Detheux Michel Chief Executive Officer   •       –      –    2025-06-10 4 OE $4.30 $113,520 D/D 26,400 153,903     -
   Detheux Michel Chief Executive Officer   •       –      –    2025-06-10 4 AS $10.02 $439,708 I/I (43,883) 0     -
   Detheux Michel Chief Executive Officer   •       –      –    2025-06-10 4 AS $10.02 $84,168 D/D (8,400) 135,903     -
   Detheux Michel Chief Executive Officer   •       –      –    2025-06-09 4 AS $10.03 $440,136 I/I (43,882) 0     -
   Detheux Michel Chief Executive Officer   •       –      –    2025-06-09 4 OE $4.30 $188,693 I/I 43,882 43,882     -
   Detheux Michel Chief Executive Officer   •       –      –    2025-06-09 4 AS $10.03 $84,252 D/D (8,400) 135,903     -
   Detheux Michel Chief Executive Officer   •       –      –    2025-06-09 4 OE $4.30 $36,120 D/D 8,400 144,303     -
   Detheux Michel Chief Executive Officer   •       –      –    2025-06-06 4 AS $10.21 $448,035 I/I (43,882) 0     -
   Detheux Michel Chief Executive Officer   •       –      –    2025-06-06 4 OE $4.30 $188,693 I/I 43,882 43,882     -
   Detheux Michel Chief Executive Officer   •       –      –    2025-06-06 4 AS $10.21 $85,764 D/D (8,400) 135,903     -
   Detheux Michel Chief Executive Officer   •       –      –    2025-06-06 4 OE $4.30 $36,120 D/D 8,400 144,303     -
   Hallal David   –       •      –    2025-06-06 4 AS $10.24 $391,455 D/D (38,228) 0     -
   Hallal David   –       •      –    2025-06-06 4 OE $4.30 $164,380 D/D 38,228 38,228     -
   Detheux Michel Chief Executive Officer   •       –      –    2025-06-05 4 AS $10.15 $445,402 I/I (43,882) 0     -
   Detheux Michel Chief Executive Officer   •       –      –    2025-06-05 4 OE $4.30 $188,693 I/I 43,882 43,882     -
   Detheux Michel Chief Executive Officer   •       –      –    2025-06-05 4 AS $10.15 $85,260 D/D (8,400) 135,903     -
   Detheux Michel Chief Executive Officer   •       –      –    2025-06-05 4 OE $4.30 $36,120 D/D 8,400 144,303     -
   Hallal David   –       •      –    2025-06-05 4 AS $10.15 $388,004 D/D (38,227) 0     -

  274 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed